Hulya GUVELİ, Serap OFLAZ, Hasan BAKAY, Ertuğrul ÇEKİÇ, Sevda BAĞ

Atypical Antipsychotics Induced Chronic Akathisia: A Case Report

Akatizi huzursuzluk ve sıkıntı veren istemsiz hareketler ile karakterize bir hareket bozukluğudur. Akatizinin dört tipi mevcuttur: akut, tardif, kesilme ve kronik akatizi. İlacın tetiklediği akatiziden korunma konusunda standart titrasyon ve ikinci kuşak antipsikotiklerin kullanımı başarılı yaklaşımlar olarak bilinmektedir. Bununla birlikte, ilacın tetiklediği akatizi ikinci kuşak antipsikotiklerle de ortaya çıkabilmektedir. Özellikle akatizi kronikleştiğinde, tedavide bir takım güçlükler ortaya çıkabilmektedir. Biz bu yayında, psikotik bozukluk tedavisine yönelik çeşitli ikinci kuşak antipsikotik ilaçlar verilen ve ilaç tedavileri sonrasında akut başlangıçlı kronik akatizi gelişen bir hastayı ve bu hastanın tedavisini tartıştık.

Atipik antipsikotiklerin neden olduğu kronik akatizi: Vaka sunumu

Akathisia is a movement disorder characterized b involuntary movements resulting in discomfort an restlessness. The four subtypes of akathisia are a follows: acute, tardive, withdrawal and chronic akathisia Standardized titration and use of second generatio antipsychotics are successful approaches of preventio from drug-induced akathisia. On the other hand, it i possible that atypic antipsychotics-induced akathisi may emerge and there may be some difficulties i its management, especially when it is persistent. I this paper, we discussed a patient, who were give various second generation antipsychotics for treatmen of psychotic disorder and there after developed chroni akathisia with acute onset and its management.

PDF

___

1. Barnes TR. The Barnes Akathisia rating scalerevisited. Journal of Psychopharmacology. 2003;17:365-70.
2. Fleischhacker WW. Managing antipsychotic-induced acute and chronic akathisia. Drug Safety. 2000;22:73-81.
3. Jackson N, Doherty J, Coulter S. Neuropsychiatric complications of commonly used palliative care drugs. Postgrad Med J. 2008;84:121- 6.
4. Cole JO, Goldberg SC, Klerman GL. Phenothiazine treatment in acute schizophrenia. Arch Gen Psychiatry. 1964;10:246-61.
5. Ayd FJ, Jr. High potency neuroleptics and akathisia. J Clin Psychopharmacol. 1984;4:237.
6. Sachdev PS, Brune M. Animal models of acute drug-induced akathisia - a review. Neurosci Biobehav Rev. 2000;24:269-77.
7. Sachdev P. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive, and withdrawal akathisias. Schizophr Bull. 1995;21:451-61.
8. Kumar R, Sachdev PS. Akathisia and second-generation antipsychotic drugs. Curr Opin Psychiatry. 2009;22:293-99.
9. Sachdev P. Research diagnostic criteria for drug-induced akathisia: conceptualization, rationale and proposal. Psychopharmacology. 1994;114:181-6.
10. Nasrallah HA, Brecher M, Paulsson B. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania. Bipolar Disord. 2006;8:467- 74.
11. Hieber R, Dellenbaugh T, Nelson LA. Role of mirtazapine in the treatment of antipsychotic-induced akathisia. Ann Pharmacother. 2008;42:841-6.
12. Cortese L, Caligiuri MP, Williams R, Schieldrop P, Manchanda R, Malla A, et al. Reduction in neuroleptic-induced movement disorders after a switch to quetiapine in patients with schizophrenia. J Clin Psychopharmacol. 2008;28:69-73.